Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio

On the morning of January 3,Kexing Biopharm signed an international commercialization cooperation agreement onEribulin Mesylate Injection, securing exclusive commercialization licensing and supply of the product from Xiling Lab Co., Ltd. in 36

Related Keywords

Argentina ,Xiling ,Guangdong ,China ,Singapore ,United States ,India ,Thailand ,Egypt ,Brazil ,South Africa ,Saudi Arabia ,Kexing Biopharm ,Health Protection ,Xiling Lab Co Ltd ,Eribulin Mesylate Injection ,Mesylate Injection ,Precise Products ,Predictable Effects ,Albumin Bound Paclitaxel ,